Literature DB >> 10683326

Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.

E Konishi1, M Yamaoka, I Kurane, P W Mason.   

Abstract

Swine are an important amplifier of Japanese encephalitis (JE) virus in the paradomestic environment. In this study, two JE DNA vaccine candidates were evaluated for immunogenicity in swine. Both vaccine plasmids encode a cassette consisting of the signal of premembrane (prM), prM, and envelope (E) coding regions of JE virus. One plasmid, designated pcJEME, is based on a commercial vector (pcDNA3), whereas the other plasmid, designated pNJEME, is based on a vector (pNGVL4a) designed to address some of the safety concerns of DNA vaccine use. No differences were detected in the immunogenicity of these two plasmids in mice or swine. Swine immunized with the DNA vaccines at a dose of 100 to 450 microgram at an interval of 3 weeks developed neutralizing and hemagglutination-inhibitory (HAI) antibody titers of 1:40 to 1:160 at 1 week after the second immunization. However, swine administered two doses of a commercial JE vaccine (formalin-inactivated virus preparation; JEVAX-A) developed low (1:10) or undetectable antibody responses after their boost. Interestingly, serum antibody titers elicited by DNA vaccines in swine were higher than those detected in mice. Eight days after boosting with viral antigen (JEVAX-A) to detect an anamnestic response, swine immunized two times with the DNA vaccine showed a >100-fold elevation in HAI titer, indicating a strong recall of antibody response. Swine maintained detectable levels of HAI antibody for at least 245 days after two immunizations with a DNA vaccine. These results indicate that these DNA vaccines are able to induce virus-specific memory B cells and long-lasting antibodies in swine, which were of higher levels than those obtained with a commercial formalin-inactivated JE vaccine. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683326     DOI: 10.1006/viro.1999.0142

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.

Authors:  A V Timofeev; V M Butenko; J R Stephenson
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

2.  Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus.

Authors:  M Giese; U Bahr; N J Jakob; R Kehm; M Handermann; H Müller; T H Vahlenkamp; C Spiess; T H Schneider; G Schusse; G Darai
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

3.  Production and characterization of vaccines based on flaviviruses defective in replication.

Authors:  Peter W Mason; Alexandr V Shustov; Ilya Frolov
Journal:  Virology       Date:  2006-05-18       Impact factor: 3.616

4.  Production of pseudoinfectious yellow fever virus with a two-component genome.

Authors:  Alexandr V Shustov; Peter W Mason; Ilya Frolov
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 5.  Development of a recombinant vaccine against Japanese encephalitis.

Authors:  Rupinderjeet Kaur; Sudhanshu Vrati
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

6.  Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination.

Authors:  Yu Zhang; Puyan Chen; Ruibing Cao; Jinyan Gu
Journal:  Virol J       Date:  2011-03-25       Impact factor: 4.099

7.  Inhibition of Japanese encephalitis virus NS1 protein expression in cell by small interfering RNAs.

Authors:  Xueqin Liu; Shengbo Cao; Rui Zhou; Gaoyuan Xu; Shaobo Xiao; Ying Yang; Minxuan Sun; Yaoming Li; Huanchun Chen
Journal:  Virus Genes       Date:  2006-08       Impact factor: 2.198

8.  Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line.

Authors:  Fuquan Zhang; Wenyu Ma; Li Zhang; Marlen Aasa-Chapman; Hongyi Zhang
Journal:  Virol J       Date:  2007-02-26       Impact factor: 4.099

Review 9.  Biomarkers in Japanese encephalitis: a review.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2013-12-18       Impact factor: 3.411

10.  Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.

Authors:  Ayan Dey; T M Chozhavel Rajanathan; Harish Chandra; Hari P R Pericherla; Sanjeev Kumar; Huzaifa S Choonia; Mayank Bajpai; Arun K Singh; Anuradha Sinha; Gurwinder Saini; Parth Dalal; Sarosh Vandriwala; Mohammed A Raheem; Rupesh D Divate; Neelam L Navlani; Vibhuti Sharma; Aashini Parikh; Siva Prasath; M Sankar Rao; Kapil Maithal
Journal:  Vaccine       Date:  2021-06-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.